The worldwide recognition of Juvenile myoclonic epilepsy (JME), or Janz Syndrome, has created confusion about the criteria, treatment in the different age groups, and lifestyle recommendations. Patients with JME still face suboptimal management.
In the past five years many studies in JME patients have provided new insights, which will be addressed in the International Conference on JME held at the Bel Air Hotel, The Hague, The Netherlands on October 26th - 28th 2012
|
When you attend, you will gain:
- A better understanding of the multiple genetic factors involved
- More knowledge of the complex clinical phenotype which includes neuropsychological and psychiatric elements
- More knowledge about circadian mechanisms and interaction with the environment
- New concepts about the relationship between JME and other forms of epilepsies
- A better understanding of the long-term evolution
- Insights into new therapeutic strategies
Your questions and case histories can be discussed with the distinguished faculty as well as with the 'father' of JME: Prof Dr Dieter Janz from Berlin, Germany. |
| Call for Abstracts |
|
Abstract submission deadline: July 20th 2012
The conference welcomes submissions on all JME topics, including but not limited to:
- JME and treatment
- JME and provocative factors
- JME in families
- JME and behavior
- JME and EEG
For more information please visit: www.juvenile-myoclonic-epilepsy.com
|
